| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | -1,1 k € | -130.1% | 3,7 k € | +187.2% | -4,3 k € | -120.5% | 21,0 k € | |
| EBITDA | -1,6 k € | -148.1% | 3,3 k € | +169.6% | -4,7 k € | -123.0% | 20,6 k € | |
| Operating profit | -1,6 k € | -148.1% | 3,3 k € | +169.6% | -4,7 k € | -123.0% | 20,6 k € | |
| Profit/loss | -1,3 k € | -137.8% | 3,6 k € | +176.8% | -4,6 k € | -128.6% | 16,2 k € | |
| Equity | 5,3 k € | -68.2% | 16,6 k € | +27.3% | 13,1 k € | -26.2% | 17,7 k € | |
| Total assets | 17,0 k € | -11.1% | 19,1 k € | +45.8% | 13,1 k € | -40.7% | 22,0 k € | |
| Cash | 8,7 k € | -9.2% | 9,6 k € | +104.7% | 4,7 k € | -62.3% | 12,5 k € | |
| Debts | 11,7 k € | +381.6% | 2,4 k € | 0,0 € | -100.0% | 4,3 k € | ||
Source: Belgian Official Gazette
Private limited company · Alken · incorporated on 21/01/2022
Private limited company loss-making in the latest fiscal year. Cash position declining (-9.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
| Unit no. | Name | Location |
|---|---|---|
| 2327009214 | EB Pharma Developments | Alkerstraat 28, 3570 Alken |
EB Pharma Developments is a Private limited company incorporated in 2022. Its main activity is: Autres activités spécialisées, scientifiques et techniques. Its registered office is in Alken.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.